DESITIN PHARMA A/S: Financial statements 2018
CVR: 19389006
Source: annual report 2018, Danish Business Authority
01/10/2017 – 30/09/2018
DESITIN PHARMA A/S (CVR 19389006) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 6,012,108 and a net result of DKK 1,515,573 compared with DKK 629,530 the year before. That is an increase of 30.8% compared with the year before. Equity in the 2018 report amounted to DKK 5,118,082. The solvency ratio was 77%.
- Gross Profit
- DKK 6,012,108
- Profit/Loss
- DKK 1,515,573
- Equity
- DKK 5,118,082
- Total Assets
- DKK 6,647,345
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 6 mio. | 1.5 mio. | 5.1 mio. | - |
| 2017 | - | 4.6 mio. | 630 t. | 3.6 mio. | - |
| 2016 | - | 5.6 mio. | 1.2 mio. | 3.7 mio. | - |
| 2015 | - | 7.4 mio. | 2.4 mio. | 3.7 mio. | - |
| 2014 | - | 958 t. EUR | 287 t. EUR | 379 t. EUR | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
As of March 1, 2018, Christian Eric Schmolck has joined the board of directors of DESITIN PHARMA A/S.
As of February 28, 2018, Hans-Jurgen Tacke has left the board of directors of DESITIN PHARMA A/S.
About DESITIN PHARMA A/S
DESITIN PHARMA A/S is a Danish company of the type Aktieselskab based in København V, founded in 1996. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Eli Lønne. The board consists of Philipp Andreas Bloching (chair), Eli Lønne and Oliver Christoph. The company is owned by Desitin Arzneimittel GmbH. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK 2,151,761 and a net result of DKK 288,733 compared with DKK 285,567 the year before. Equity in the 2025 report amounted to DKK 7,044,140.